跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xylocaine 2.0% 40mg/2mL injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
Xylocaine 2.0% 40mg/2mL injection ampoule
Approved
STANDARD
Xylocaine 2.0% 40mg/2mL injection ampoule
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 31, 2025
Approval ID
7ef09459e3f35f00
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
7ef09459e3f35f00
Product Name
Xylocaine 2.0% 40mg/2mL injection ampoule
Artg Id
12020
Artg Name
XYLOCAINE 2% lidocaine (lignocaine) hydrochloride 40mg/2mL injection ampoule
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
1991-08-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/98bd54e88d0daa3c4d9e6796c6f126e1.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/04ababeadb8a5421338286e34219be9a.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 31, 2025
Approval ID
7ef09459e3f35f00
Type
Standard
Back to TGA Approvals